Letko, Brosseau & Associates’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $80.3M | Buy |
1,199,240
+5,894
| +0.5% | +$431K | 1.19% | 34 |
|
|
2026
Q1 | $91.1M | Sell |
1,193,346
-1,075
| -0.1% | -$77.5K | 1.47% | 26 |
|
|
2025
Q4 | $76.2M | Buy |
1,194,421
+61,950
| +5% | +$3.82M | 1.25% | 30 |
|
|
2025
Q3 | $71.4M | Buy |
1,132,471
+281,875
| +33% | +$19.7M | 1.23% | 32 |
|
|
2025
Q2 | $63.5M | Buy |
850,596
+21,070
| +3% | +$1.66M | 1.21% | 34 |
|
|
2025
Q1 | $73.1M | Sell |
829,526
-13,540
| -2% | -$1.28M | 1.55% | 25 |
|
|
2024
Q4 | $77M | Sell |
843,066
-8,035
| -0.9% | -$824K | 1.49% | 23 |
|
|
2024
Q3 | $95.3M | Buy |
851,101
+2,350
| +0.3% | +$235K | 1.73% | 19 |
|
|
2024
Q2 | $83.2M | Sell |
848,751
-9,265
| -1% | -$919K | 1.58% | 24 |
|
|
2024
Q1 | $86M | Buy |
858,016
+897
| +0.1% | +$78.9K | 1.49% | 25 |
|
|
2023
Q4 | $77M | Buy |
857,119
+87,845
| +11% | +$7M | 1.4% | 27 |
|
|
2023
Q3 | $59M | Buy |
769,274
+6,725
| +0.9% | +$558K | 1.16% | 35 |
|
|
2023
Q2 | $63.8M | Buy |
762,549
+127,135
| +20% | +$10.3M | 1.19% | 31 |
|
|
2023
Q1 | $53.6M | Buy |
635,414
+4,340
| +0.7% | +$373K | 1% | 40 |
|
|
2022
Q4 | $51.4M | Buy |
631,074
+3,200
| +0.5% | +$258K | 0.93% | 39 |
|
|
2022
Q3 | $44.6M | Sell |
627,874
-305
| -0% | -$27.4K | 0.88% | 43 |
|
|
2022
Q2 | $56.4M | Buy |
628,179
+51,075
| +9% | +$5.29M | 1% | 33 |
|
|
2022
Q1 | $64.7M | Sell |
577,104
-20,250
| -3% | -$2.37M | 0.96% | 33 |
|
|
2021
Q4 | $72.2M | Sell |
597,354
-13,035
| -2% | -$1.45M | 1.03% | 32 |
|
|
2021
Q3 | $61.5M | Sell |
610,389
-36,075
| -6% | -$3.98M | 0.89% | 42 |
|
|
2021
Q2 | $75.5M | Sell |
646,464
-45,097
| -7% | -$5.41M | 1.01% | 37 |
|
|
2021
Q1 | $76.2M | Sell |
691,561
-56,335
| -8% | -$6.12M | 1.04% | 35 |
|
|
2020
Q4 | $75M | Sell |
747,896
-156,275
| -17% | -$14.5M | 1.03% | 31 |
|
|
2020
Q3 | $70.6M | Sell |
904,171
-131,965
| -13% | -$9.95M | 1.1% | 32 |
|
|
2020
Q2 | $72.2M | Buy |
1,036,136
+198,400
| +24% | +$12.5M | 1.07% | 35 |
|
|
2020
Q1 | $39M | Sell |
837,736
-22,375
| -3% | -$1.44M | 0.67% | 45 |
|
|
2019
Q4 | $68.2M | Sell |
860,111
-25,750
| -3% | -$1.98M | 0.68% | 48 |
|
|
2019
Q3 | $65.4M | Sell |
885,861
-22,400
| -2% | -$1.61M | 0.67% | 47 |
|
|
2019
Q2 | $70.7M | Sell |
908,261
-33,785
| -4% | -$2.57M | 0.71% | 46 |
|
|
2019
Q1 | $71.5M | Buy |
942,046
+7,999
| +0.9% | +$636K | 0.71% | 46 |
|
|
2018
Q4 | $68.3M | Buy |
934,047
+202,682
| +28% | +$16.2M | 0.76% | 42 |
|
|
2018
Q3 | $70M | Sell |
731,365
-31,495
| -4% | -$3.12M | 0.65% | 50 |
|
|
2018
Q2 | $76.3M | Sell |
762,860
-48,160
| -6% | -$5.08M | 0.7% | 46 |
|
|
2018
Q1 | $85.6M | Sell |
811,020
-9,825
| -1% | -$993K | 0.81% | 41 |
|
|
2017
Q4 | $76M | Sell |
820,845
-4,225
| -0.5% | -$384K | 0.67% | 46 |
|
|
2017
Q3 | $74.7M | Buy |
825,070
+6,640
| +0.8% | +$565K | 0.68% | 46 |
|
|
2017
Q2 | $68.7M | Buy |
818,430
+152,395
| +23% | +$12.3M | 0.67% | 47 |
|
|
2017
Q1 | $53.8M | Buy |
666,035
+99,035
| +17% | +$7.79M | 0.5% | 52 |
|
|
2016
Q4 | $42.6M | Buy |
+567,000
| New | +$40.9M | 0.39% | 58 |
|
Other funds holding EMN
Letko, Brosseau & Associates's EMN Position: Q2 2026 in Review
Letko, Brosseau & Associates increased its Eastman Chemical (EMN) stake by 0.49% in Q2 2026, buying an estimated $431K and bringing the position to 1,199,240 shares worth $80.3M. The position accounts for 1.19% of the portfolio, ranked #34.
Letko, Brosseau & Associates first reported a position in EMN in Q4 2016 and has held it in 39 quarters since. The position peaked at $95.3M in Q3 2024. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Letko, Brosseau & Associates held 1,199,240 shares of Eastman Chemical worth $80.3M as of Q2 2026.
- Letko, Brosseau & Associates bought 5,894 Eastman Chemical shares in Q2 2026, an estimated $431K.
- Eastman Chemical made up 1.19% of Letko, Brosseau & Associates's portfolio in Q2 2026, its #34 holding.
- Letko, Brosseau & Associates first reported a position in Eastman Chemical in Q4 2016 and has held it in 39 quarters since.
- Letko, Brosseau & Associates's Eastman Chemical position peaked at $95.3M in Q3 2024.
- 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Letko, Brosseau & Associates's 13F filing for Q2 2026, filed 13 Aug 2026.